NasdaqGM - Delayed Quote USD

Nano-X Imaging Ltd. (NNOX)

5.60
+0.15
+(2.75%)
At close: May 16 at 4:00:00 PM EDT
5.58
-0.02
(-0.36%)
After hours: May 16 at 7:59:02 PM EDT
Loading Chart for NNOX
  • Previous Close 5.45
  • Open 5.48
  • Bid 5.59 x 300
  • Ask 5.63 x 400
  • Day's Range 5.47 - 5.65
  • 52 Week Range 3.75 - 11.00
  • Volume 854,926
  • Avg. Volume 1,507,324
  • Market Cap (intraday) 357.067M
  • Beta (5Y Monthly) 2.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.91
  • Earnings Date May 22, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.75

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.

www.nanox.vision

165

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NNOX

View More

Performance Overview: NNOX

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NNOX
22.22%
S&P 500 (^GSPC)
1.30%

1-Year Return

NNOX
43.03%
S&P 500 (^GSPC)
12.48%

3-Year Return

NNOX
41.67%
S&P 500 (^GSPC)
48.66%

5-Year Return

NNOX
72.47%
S&P 500 (^GSPC)
108.07%

Compare To: NNOX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NNOX

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    357.07M

  • Enterprise Value

    291.31M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    29.12

  • Price/Book (mrq)

    1.89

  • Enterprise Value/Revenue

    25.82

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -16.52%

  • Return on Equity (ttm)

    -27.83%

  • Revenue (ttm)

    11.28M

  • Net Income Avi to Common (ttm)

    -53.52M

  • Diluted EPS (ttm)

    -0.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    73.21M

  • Total Debt/Equity (mrq)

    3.94%

  • Levered Free Cash Flow (ttm)

    -19.41M

Research Analysis: NNOX

View More

Company Insights: NNOX

Research Reports: NNOX

View More

People Also Watch